Functional and radiologic evidence of vascular communication between the spongiosal and cavernosal compartments of the penis

Urology

Volumn 49, Issue 5, 1997, Pages 749-752

  Vardi, Yoram ^b   Saenz de Tejada, Iñigo ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E1;

ARTICLE; CLINICAL ARTICLE; CORPUS CAVERNOSUM; DRUG ABSORPTION; HUMAN; IMPOTENCE; INTRACAVERNOUS DRUG ADMINISTRATION; MALE; PENIS ERECTION; PENIS GLANS; PRIORITY JOURNAL;

HUMANS; MALE; PENIS;

EID: 0343417032     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00085-X     Document Type: Article

References (12)

1. Virag R, Shoukry K, Floresco J, Nollet F, and Greco E: Intracavernous self-injection of vasoactive drugs in the treatment of erectile dysfunction: 8-year experience with 615 cases. J Urol 145: 287-292, 1991.
2. Altof SE, Turner LA, Levine SB, Risen C, Kursh E, Bodner D, and Resnick M: Why do so many people drop out from auto-injection therapy for impotence? J Sex Marital Ther 15: 121-129, 1989.
3. Pery M, Rosenberger A, Kaftori JK, and Vardi Y: Intracorporeal calcifications after self-injection of papaverine. Radiology 176: 81-83, 1990.
4. Ballard SA, Burslem FMF, Gingell CJC, Price ME, Tang K, Turner LA, and Naylor AM: In vitro profile of UK-92,480, an inhibitor of cyclic GMP-specific phosphodiesterase V for the treatment of male erectile dysfunction (abstract 1462). J Urol 155: 676A, 1996.
5. Kim ED, El-Rashidy R, and McVary KT: Papaverine topical gel for treatment of erectile dysfunction. J Urol 153: 361-365, 1995.
6. Padma-Nathan H, Keller T, Proppiti R, Lue T, Tam P, and Place V: Hemodynamic effects of intraurethral alprostadil: the medicated urethral system for erection (MUSE). Int J Impotence Res 6(suppl 1): A42, 1994.
7. Eardley I, Morgan RJ, Dinsmore WW, Pearson J, Wulff MB, and Boolell M: UK-92,480, a new oral therapy for erectile dysfunction. A double blind, placebo-controlled trial with treatment taken as required (abstract 737). J Urol 155: 495A, 1996.
8. Padma-Nathan H, Hellstrom WJG, Kaiser FE, et al: Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med 336: 1-7, 1997.
9. SAS Institute User's Guide, Version 6, 4th ed. Cary, NC, SAS Institute, 1990.
10. Saenz de Tejada I, Moroukian P, Tessier J, Kim JJ, Goldstein I, and Frohrib D: Trabecular smooth muscle modulates the capacitor function of the penis. Studies on a rabbit model. Am J Physiol 260: H1590-H1595, 1991.
11. Hatzichristou DG, Saenz de Tejada I, Kupferman S, Namburi S, Pescatori ES, Udelson D, and Goldstein I: In vivo assessment of trabecular smooth muscle tone, its application in pharmaco-cavernosometry and analysis of intracavernous pressure determinant. J Urol 153: 1126-1135, 1995.
12. Halata Z, and Brycel BL: The neuroanatomical basis of the protopathic sensitivity of the human glans penis. Brain Res 371: 205-230, 1986.